Paper41590658
Plasma Galectin-7 (Gal-7) and Galectin-8 (Gal-8) as Emerging Biomarkers in Psoriasis: Associations with Disease Activity and Metabolic Status.
Nowowiejska-Purpurowicz J and 6 others. Metabolites, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Plasma Galectin-7 (Gal-7) and Galectin-8 (Gal-8) as Emerging Biomarkers in Psoriasis: Associations with Disease Activity and Metabolic Status. Papers, record 41590658. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41590658
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Plasma Galectin-7 (Gal-7) and Galectin-8 (Gal-8) as Emerging Biomarkers in Psoriasis: Associations with Disease Activity and Metabolic Status.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| SUB/1/DN/22/001/1149 | Medical University of Białystok | PubMed |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 41226378 | Plasma Galectin-4 and Charcot-Leyden Crystal Protein/Galectin-10 as Emerging Biomarkers of Metabolically Induced Inflammation in Patients with Psoriasis. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41226378 | PubMed |
| 2 | 40428884 | Clinical Effectiveness, Clinical Stability, and Effects on Serum Galectin-7 Levels of Dupilumab and JAK Inhibitors in Moderate-to-Severe Atopic Dermatitis: A Real-World, Single-Center Analysis. | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/40428884 | PubMed |
| 3 | 40930460 | Global Burden of Psoriasis from 1990 to 2021 and Potential Factors: A Systematic Analysis. | J Invest Dermatol | 2026 | https://conductscience.org/library/papers/40930460 | PubMed |
| 4 | 32805218 | Galectin-8 Is Upregulated in Keratinocytes by IL-17A and Promotes Proliferation by Regulating Mitosis in Psoriasis. | J Invest Dermatol | 2021 | https://conductscience.org/library/papers/32805218 | PubMed |
| 5 | 32427307 | Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review. | JAMA | 2020 | https://conductscience.org/library/papers/32427307 | PubMed |
| 6 | 31336500 | The association between psoriasis and diabetes mellitus: A systematic review and meta-analysis. | Diabetes Metab Syndr | 2019 | https://conductscience.org/library/papers/31336500 | PubMed |
| 7 | 33055419 | Galectin-7 downregulation in lesional keratinocytes contributes to enhanced IL-17A signaling and skin pathology in psoriasis. | J Clin Invest | 2021 | https://conductscience.org/library/papers/33055419 | PubMed |
| 8 | 37892153 | Evaluation of Plasma Concentrations of Galectins-1, 2 and 12 in Psoriasis and Their Clinical Implications. | Biomolecules | 2023 | https://conductscience.org/library/papers/37892153 | PubMed |
| 9 | 29128465 | Psoriasis and the risk of diabetes: A prospective population-based cohort study. | J Am Acad Dermatol | 2018 | https://conductscience.org/library/papers/29128465 | PubMed |
| 10 | 39000133 | Mild Systemic Inflammation Increases Erythrocyte Fragility. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39000133 | PubMed |
| 11 | 34577817 | Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Diagnosis and Management. | Medicina (Kaunas) | 2021 | https://conductscience.org/library/papers/34577817 | PubMed |
| 12 | 36693903 | Galectin-7 reprograms skin carcinogenesis by fostering innate immune evasive programs. | Cell Death Differ | 2023 | https://conductscience.org/library/papers/36693903 | PubMed |
| 13 | 30909615 | Psoriasis Pathogenesis and Treatment. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/30909615 | PubMed |
| 14 | 40920142 | Galectins in Inflammatory Skin Diseases: Mechanisms and Therapeutic Potential. | J Invest Dermatol | 2026 | https://conductscience.org/library/papers/40920142 | PubMed |
| 15 | 17021763 | Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. | Arch Dermatol Res | 2006 | https://conductscience.org/library/papers/17021763 | PubMed |
| 16 | 38092632 | The elevation of plasma galectin-9 levels in patients with psoriasis and its associations with inflammatory and immune checkpoint molecules in skin tissues. | Hum Immunol | 2024 | https://conductscience.org/library/papers/38092632 | PubMed |
| 17 | 26763438 | Galectin-7 Regulates Keratinocyte Proliferation and Differentiation through JNK-miR-203-p63 Signaling. | J Invest Dermatol | 2016 | https://conductscience.org/library/papers/26763438 | PubMed |
| 18 | 35015084 | Galectin-8, cytokines, and the storm. | Biochem Soc Trans | 2022 | https://conductscience.org/library/papers/35015084 | PubMed |
| 19 | 35053087 | Galectin-3 as a Novel Multifaceted and Not Only Cardiovascular Biomarker in Patients with Psoriasis with Regard to Systemic Treatment-Preliminary Data. | Biology (Basel) | 2022 | https://conductscience.org/library/papers/35053087 | PubMed |
| 20 | 18829868 | Galectin-7 in the control of epidermal homeostasis after injury. | Mol Biol Cell | 2008 | https://conductscience.org/library/papers/18829868 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| LGALS7 | 3963 | PubTator's text mining | https://conductscience.org/library/genes/3963 | NCBI Gene |
| LGALS8 | 3964 | PubTator's text mining | https://conductscience.org/library/genes/3964 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41590658
GET https://conductscience.org/api/papers/v1/41590658/references?page=2